A phase 1 trial and pharmacokinetic study of cediranib, an orally bioavailable pan-vascular endothelial growth factor receptor inhibitor, in children and adolescents with refractory solid tumors (Q34488671)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 1 trial and pharmacokinetic study of cediranib, an orally bioavailable pan-vascular endothelial growth factor receptor inhibitor, in children and adolescents with refractory solid tumors |
scientific article |
Statements
1 reference
A phase 1 trial and pharmacokinetic study of cediranib, an orally bioavailable pan-vascular endothelial growth factor receptor inhibitor, in children and adolescents with refractory solid tumors (English)
1 reference
Elizabeth Fox
1 reference
Richard Aplenc
1 reference
Rochelle Bagatell
1 reference
Meredith K Chuk
1 reference
Eva Dombi
1 reference
Wendy Goodspeed
1 reference
Anne Goodwin
1 reference
Marie Kromplewski
1 reference
Nalini Jayaprakash
1 reference
Marcelo Marotti
1 reference
Kathryn H Brown
1 reference
Barbara Wenrich
1 reference
Peter C Adamson
1 reference
Brigitte C Widemann
1 reference
Frank M Balis
1 reference
8 November 2010
1 reference
1 reference
28
1 reference
35
1 reference
5174-5181
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference